Here's the quick infographic
The side effects of Wegovy are often non-serious, with 99.5% of gastrointestinal events categorised as such, and 98.1% were mild to moderate in severity
Stopping GLP-1 treatment, even briefly, significantly increases the risk of major cardiovascular events including heart attack, stroke and death
CMS announced changes to Medicare coverage of GLP-1 medications are not expected to affect Medicaid coverage of the medications under the BALANCE model
Ozempic and type 2 diabetes In the SUSTAIN 1 trial (NCT02054897), 73% of people with type 2 diabetes taking Ozempic 0.5 mg injection reached an A1C of 7% or less within 30 weeks
Recent comprehensive analyses, including systematic reviews and meta-analyses, indicate that sulforaphane, a compound derived from cruciferous vegetables like broccoli sprouts, has shown promising results in improving ASD symptoms